Synlett 2008(16): 2495-2499  
DOI: 10.1055/s-2008-1078177
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Biginelli-Atwal Reactions of (+)-Pulegone: An Entry into Chiral Hexahydroquinazolin-2-one Derivatives

Mohamed Tabouazata,b, Ahmed El Louzia, Mohammed Ahmarb, Bernard Cazes*b
a LCPSOB, Université Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco
b ICBMS-UMR 5246, Université LYON 1-CNRS, Bât. CPE-Lyon, 43 Bd. du 11 Novembre 1918, 69622 Villeurbanne, France
Fax: +33(4)72431214; e-Mail: cazes@univ-lyon1.fr;
Further Information

Publication History

Received 28 April 2008
Publication Date:
10 September 2008 (online)

Abstract

Biginelli-Atwal condensations of (+)-pulegone with (thio)ureas and guanidine afford hexahydroquinazoline-2(1H)-ones (-thiones) and/or 2-amino-1,3-thiazines with selectivities that depend on both the (thio)ureas and the experimental conditions. Carboannelation of these heterocyclic adducts with diethyl ethoxymethylenemalonate leads to uncommon pyrimidoquinazoline and pyrimidobenzothiazine systems.

    References and Notes

  • 1a Biginelli P. Ber. Dtsch. Chem. Ges.  1891,  24:  1317 
  • 1b Biginelli P. Gazz. Chim. Ital.  1893,  23:  360 
  • 1c Folkers K. Harwood HJ. Johnson TB. J. Am. Chem. Soc.  1932,  54:  3751 
  • 1d Kappe CO. J. Org. Chem.  1997,  62:  7201 
  • For comprehensive reviews on Biginelli reaction, see:
  • 2a Kappe CO. Tetrahedron  1993,  49:  6937 
  • 2b Kappe CO. Acc. Chem. Res.  2000,  33:  879 
  • 2c Kappe CO. Stadler A. Org. React.  2004,  63:  1 
  • 2d Simon C. Constantieux T. Rodriguez J. Eur. J. Org. Chem.  2004,  4957 
  • 2e Kappe CO. Multicomponent Reactions   Zhu J. Bienaymé H. Wiley-VCH; Weinheim: 2005.  p.95-120  
  • 3a Janis RA. Silver PJ. Triggle DJ. Adv. Drug Res.  1987,  16:  309 
  • 3b Bossert F. Vater W. Med. Res. Rev.  1989,  9:  291 
  • 4 For a review about biologically active DHPM, see: Kappe CO. Eur. J. Med. Chem.  2000,  35:  1043 
  • 5 Hurst EW. Hull R. J. Med. Chem. Pharm.  1961,  3:  215 
  • 6 Kato T. inventors; JP  59190974.  ; Chem. Abstr. 1985, 102, 132067m
  • 7 Bruce MA, Poindexter GS, and Johnson G. inventors; WO  9833791.  ; Chem. Abstr. 1998, 129, 148989g
  • 8a Kappe CO. Molecules  1998,  3:  1 
  • 8b Kappe CO. QSAR Comb. Sci.  2003,  22:  630 
  • 9 Barrow JC. Nantermet PG. Selnick HG. Glass KL. Rittle KE. Freidinger RM. Ransom RW. O’Malley SS. Eppert P. Nagarathnam D. Forray C. J. Med. Chem.  2000,  43:  2703 
  • 10a Hassani Z. Islami MR. Kalantari M. Bioorg. Med. Chem. Lett.  2006,  16:  4479 
  • 10b Lin H. Zhaoa Q. Xua B. Wanga X. J. Mol. Catal. A: Chem.  2007,  268:  221 
  • 11 Yarim M. Saraç S. Kiliç FS. Erol K. Il Farmaco  2003,  58:  17 
  • 12 Kidwai M. Saxena S. Khan MKR. Thukral SS. Eur. J. Med. Chem.  2005,  816 
  • 13a Mayer TU. Kapoor TM. Haggarty SJ. King RW. Schreiber SL. Mitchison TJ. Science  1999,  286:  971 
  • 13b Cheng J. Quidong Y. Zhiyu L. Quinglong G. Exp. Opin. Ther. Pat.  2006,  16:  1517 
  • 14a Gartner M. Sunder-Plassmann N. Seiler J. Utz M. Vernos I. Surrey T. Giannis A. ChemBioChem  2005,  6:  1173 
  • 14b Sarli V. Giannis A. ChemMedChem  2006,  1:  293 
  • 14c Müller C. Gross D. Sarli V. Gartner M. Giannis A. Bernhardt G. Buschauer A. Cancer Chemother. Pharmacol.  2007,  59:  157 
  • 15a Patil AD. Vasant Kumar N. Kokke WC. Bean MF. Freyer AJ. De Brosse C. Mai S. Truneh A. Faulkner DJ. Carte B. Breen AL. Hertzberg RP. Johnson RK. Westley JW. Potts BCM. J. Org. Chem.  1995,  60:  1182 
  • 15b Snider BB. Shi Z. J. Org. Chem.  1993,  58:  3828 
  • 15c Overman LE. Rabinowitz MH. Renhowe PA. J. Am. Chem. Soc.  1995,  117:  2657 
  • 16a Chen W.-Y. Quin S.-D. Jin J.-R. Synth. Commun.  2007,  37:  47 
  • 16b Debache A. Boumoud B. Amimour M. Belfaitah A. Rhouati S. Carboni B. Tetrahedron Lett.  2006,  47:  5697 
  • 16c van Lier JE. Ahmed N. Tetrahedron Lett.  2007,  48:  5407 ; and references cited therein
  • 17a Li J.-T. Han J.-F. Yang J.-H. Li T.-S. Ultrason. Sonochem.  2003,  10:  119 
  • 18a Desai B. Dallinger D. Kappe CO. Tetrahedron  2006,  62:  4651 
  • 18b Xue S. Shen YC. Li YL. Shen XM. Guo QX. Chin. J. Chem.  2002,  20:  385 
  • 19a Peng JJ. Deng YQ. Tetrahedron Lett.  2001,  42:  5917 
  • 19b Legeay J.-C. Vanden Eynde JJ. Bazureau JP. Tetrahedron  2005,  61:  12386 
  • 20a Kappe CO. Uray G. Roschger P. Lindmer W. Kratky C. Keller W. Tetrahedron  1992,  48:  5473 
  • 20b Muñoz-Muñiz O. Juaristi E. Arkivoc  2003,  (xi):  16 
  • 20c Lou S. Taoka BM. Ting A. Schaus SE. J. Am. Chem. Soc.  2005,  127:  11256 
  • 20d Huang Y. Yang F. Zhu C. J. Am. Chem. Soc.  2005,  127:  16386 
  • 20e Chen X.-H. Xu X.-Y. Liu H. Cun L.-F. Gong L.-Z. J. Am. Chem. Soc.  2005,  128:  14802 
  • For reaction of guanidine, see:
  • 21a Traube W. Schwarz R. Ber. Dtsch. Chem. Ges.  1899,  32:  3163 
  • 21b Wendelin W. Harler A. Monatsh. Chem.  1974,  105:  563 
  • For reaction of urea, see:
  • 22a Harvey MT. inventors; US 2592  565.  ; Chem. Abstr. 1953, 47, 601d
  • 22b Hatt HH. Triffet ACK. J. Chem. Soc., Chem. Commun.  1965,  439 
  • 22c Zigeuner G. Fuch E. Galatik W. Monatsh. Chem.  1966,  97:  43 
  • 22d Hatt HH. Lichtenwalter GD. Riesser GH. Aust. J. Chem.  1970,  23:  561 
  • 22e Butler AR. Hussain I. J. Chem. Soc., Perkin Trans. 2  1980,  232 
  • Reactions under neutral conditions:
  • 23a Wendelin W. Harler A. Monatsh. Chem.  1975,  106:  1479 
  • 23b Wendelin W. Harler A. Fuchsgruber A. Monatsh. Chem.  1976,  107:  141 
  • Reactions under acidic conditions:
  • 24a Zigeuner G. Eisenreich V. Weichsel H. Adam W. Monatsh. Chem.  1970,  101:  1731 
  • 24b Zigeuner G. Gübitz G. Eisenreich V. Monatsh. Chem.  1970,  101:  1686 
  • Reactions under basic conditions:
  • 25a Zimmerman R. Brähler B. Hotze H. Angew. Chem.  1960,  72:  78 
  • 25b Zigeuner G. Strallhofer T. Wede F. Lintschinger W. Monatsh. Chem.  1975,  106:  1469 
  • 25c El-Rayyes NR. J. Heterocycl. Chem.  1982,  19:  415 
  • 25d El-Rayyes NR. Ramadan HM. J. Heterocycl. Chem.  1987,  24:  589 
  • 25e Lorand T. Deli J. Szabo D. Foldesi A. Zschunke A. Pharmazie  1985,  40:  536 
  • 25f Joshi KC. Dandia A. Sanan S. J. Heterocycl. Chem.  1989,  26:  1397 
  • 25g Marzinzick AL. Felder ER. J. Org. Chem.  1998,  63:  723 
  • 25h Bertozzi F. Gundersen BV. Gustafsson M. Olsson R. Org. Lett.  2003,  5:  1551 
  • 25i Klimova EI. Klimova TB. Hernández SO. Martinez MG. Heterocycles  2003,  60:  2231 
  • 26 Only one result from pulegone was reported. Its reaction with free guanidine in refluxing benzene gave the corresponding 2-aminohexahydroquinazoline 17a in 74% yield. See: Weis AL. Frolow F. Vishkautsan R. J. Heterocycl. Chem.  1986,  23:  705 
  • 27a O’Reilly BC. Atwal KS. Heterocycles  1987,  26:  1185 
  • 27b Atwal KS. O’Reilly BC. Gougoutas JZ. Heterocycles  1987,  26:  1189 
  • 27c Atwal KS. Rovnyak GC. O’Reilly BC. Atwal KS. J. Org. Chem.  1989,  54:  5898 
  • For previous reports on similar access to 2-amino-1,3-thiazines, see:
  • 29a Chase BH. J. Chem. Soc.  1955,  4443 
  • 29b Zimmerman R. Angew. Chem.  1963,  75:  1025 
  • For previous work on the use of 2-aminopyrimidine derivatives for the construction of heterocycles, see:
  • 31a Greenhill JV. Jamil Ismail M. J. Chem. Soc., Perkin Trans. 2  1985,  1255 
  • 31b Kaddachi MT. Ben Amor M. Zouari S. Cossy J. Kahn P. J. Soc. Chim. Tunisie  1999,  6:  537 
  • 31c Vanden Eynde JJ. Hecq N. Kateava O. Kappe CO. Tetrahedron  2001,  57:  1785 
  • For the synthesis of heterocycles from dihydropyrimidine-2 (1H)-thiones, see:
  • 32a Kappe CO. Roschger P. J. Heterocycl. Chem.  1989,  26:  55 
  • 32b Bozing D. Sohar P. Gigler G. Kovacs G. Eur. J. Med. Chem.  1996,  31:  663 
  • 33a Chicharro JL. Prados P. de Mendoza J. J. Chem. Soc., Chem. Commun.  1994,  1193 
  • 33b Jimenez JM, Patel S, Kay D, Knegtel R, and Philps O. inventors; US  46664.  ; Chem. Abstr. 2005, 143, 326386
  • 33c Grover RK. Kesarwani AP. Srivastava GK. Kundu B. Roy R. Tetrahedron  2005,  61:  5011 
28

Typical Experimental Procedure (Table 1, entry 4) - Synthesis of (7 R )-3,4,5,6,7,8-Hexahydro-4,4,7-trimethyl-quinazolin-2 (1 H )-one (14a) To a solution of urea 3a (1.2 g, 20 mmol) in EtOH (20 mL), was added 11 N HCl (0.9 mL, 10 mmol) and (+)-pulegone (13, 1.52 g, 10 mmol). The mixture was stirred at reflux for 14 h. Most of the EtOH was evaporated, so that a solid precipitated on cooling. The solid was filtered and washed with H2O. Recrystallization from acetone gave 14a (2.33 g, 78%) as a white solid; mp 161-163 ˚C. TLC (SiO2, EtOAc): R f  = 0.18. IR (KBr, film): 3223, 2969, 2922, 1701, 1574, 1494, 1437, 1359, 1189, 1168, 740 cm. [α]D ²0 +61.1 (c 1.0; CH2Cl2). ¹H NMR (300 MHz, CDCl3): δ = 7.71 (s, 1 H,
N1-H), 5.76 (s, 1 H, N3-H), 1.95-2.00 (m, 3 H, H-5, H-7,
H-8), 1.60-1.75 (m, 3 H, H-5′, H-6, H-8′), 1.19 [s, 6 H, C(CH 3)2], 1.05-1.30 (m, 1 H, H-6′), 0.90 [d, ³ J = 5.3 Hz, 3 H, CH(CH 3)]. ¹³C NMR (75.5 MHz, CDCl3): δ = 155.9 (C=O), 126.8 (C-8a), 109.5 (C-4a), 55.3 (C-4), 34.3 (C-8), 31.4 (C-5), 29.2 and 29.0 [C(CH3)2], 28.7 (C-7), 22.5 (C-6), 21.7 [CH(CH3)]. Anal. Calcd for C11H18N2O: C, 66.97; H, 9.34; O, 23.69. Found: C, 66.88; H, 9.47; O, 23.65.

30

(7R)-3,4,4a,5,6,7-Hexahydro-1,4,4,7-tetramethylquin-azolin-2 (1H)-one(18) was obtained as a single diastereomer to which the cis-18 structure was tentatively assigned. Indeed, the ¹H NMR and ¹³C NMR spectra [δ (¹H): singlets at 0.97 and 1.13 ppm; δ (¹³C): 23.2 and 27.2 ppm] of this diastereomer show two very differentiated gem-methyl groups, which is in consideration of a CH3/H (on C-7 and
C-4a carbon atoms) cis-relationship after comparison of the molecular models of both cis- 18 and trans-18 structures. This cis-relationship is also predicted according to the plausible mechanistic pathways for the formation of hexahydroquinazolinones 14b and 18: i) acid-catalyzed 1,4-addition of the less-hindered nitrogen atom of methylurea 3b to the conjugated enone system giving a cis-diequatorial cyclohexanone intermediate; ii) intramolecular condensation of the NHMe nitrogen on the carbonyl group; iii) β-elimination of a proton, H-4a or H-8 proton, giving rise to hexahydroquinazolinone 14b or cis-18, respectively.